ROSUVST-20

ROSUVST-20 contains Rosuvastatin 20 mg for cholesterol and lipid management in patients requiring higher-strength statin therapy when prescribed by a healthcare professional.

📋 COMPOSITION
Rosuvastatin 20 mg

💊 DOSAGE FORM
Tablets

📦 PACKAGING TYPE
ALU-ALU

🗃️ PACKAGING
10 × 10

Description

ROSUVST-20 contains Rosuvastatin 20 mg in tablet form. Rosuvastatin belongs to the statin class of medicines and helps lower LDL cholesterol by reducing cholesterol production in the liver. It may be prescribed as part of a comprehensive treatment plan for patients who require significant lipid-lowering therapy and should be used under the supervision of a healthcare professional.

For related cardiovascular and diabetic formulations, explore the Cardries Biotic range from Medhexa Pharma for pharmaceutical products and business enquiries.

Therapeutic Segment

Cardiovascular Care | Lipid Management | Statins | Cholesterol Management | Cardiovascular Risk Reduction

Uses of ROSUVST-20

ROSUVST-20 may be prescribed as part of a treatment plan for patients who require substantial LDL cholesterol reduction.

Depending on the patient’s condition, healthcare professionals may use rosuvastatin for:

  • Management of elevated LDL cholesterol
  • Hypercholesterolaemia
  • Mixed dyslipidaemia
  • Hypertriglyceridaemia as part of appropriate lipid management
  • Certain inherited lipid disorders
  • Reduction of cardiovascular risk in appropriate patients
  • Homozygous familial hypercholesterolaemia as part of specialist lipid management

Rosuvastatin 20 mg is within the high-intensity statin dosing range. The appropriate strength depends on the patient’s lipid profile, cardiovascular risk, treatment goals, medical history and response to therapy.

Key Benefits of ROSUVST-20

  • LDL Cholesterol Reduction: Rosuvastatin helps reduce LDL cholesterol in the bloodstream.
  • Lipid Management: Supports management of abnormal blood lipid levels when prescribed appropriately.
  • Statin Therapy: Provides Rosuvastatin 20 mg for patients requiring a higher-strength statin regimen.
  • Cardiovascular Risk Management: May form part of a long-term strategy to reduce cardiovascular risk in appropriate patients.
  • Once-Daily Formulation: Rosuvastatin is generally administered once daily.
  • Convenient Oral Dosage Form: Supplied as tablets for oral administration.
  • ALU-ALU Packaging: Supplied in 10 × 10 ALU-ALU packaging.

How ROSUVST-20 Works

Rosuvastatin is an HMG-CoA reductase inhibitor belonging to the statin class.

It inhibits HMG-CoA reductase, an enzyme involved in cholesterol production in the liver. Consequently, the liver increases LDL receptor activity and removes more LDL cholesterol from the bloodstream.

This action lowers circulating LDL cholesterol and can also improve other components of the lipid profile. Rosuvastatin therefore helps manage cholesterol levels when combined with an appropriate diet, lifestyle measures and medical follow-up.

Common Side Effects of ROSUVST-20

Some patients may experience side effects during rosuvastatin treatment. Possible effects include:

  • Headache
  • Dizziness
  • Nausea
  • Stomach discomfort
  • Constipation
  • Muscle aches
  • Muscle pain
  • Weakness
  • Fatigue

Rosuvastatin can occasionally cause more serious muscle-related problems, including myopathy and, rarely, rhabdomyolysis.

Contact your healthcare professional if you develop unexplained or persistent muscle pain, tenderness or weakness.

Important Safety Information

Use ROSUVST-20 only under the direction of a qualified healthcare professional.

  • Do not start, stop or change the dose without medical advice.
  • Tell your doctor if you have liver disease, kidney disease, hypothyroidism or a history of muscle problems.
  • Report unexplained or persistent muscle pain, tenderness or weakness promptly.
  • Seek urgent medical attention if severe muscle symptoms occur, particularly if accompanied by unusual weakness or dark-coloured urine.
  • Rosuvastatin can cause liver enzyme abnormalities. Your healthcare professional may perform liver-function testing before treatment and subsequently when clinically appropriate.
  • Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and supplements you take because several medicines can interact with rosuvastatin.
  • Patients with severe renal impairment may require a lower dose. The appropriate rosuvastatin dose should be determined according to kidney function and the approved prescribing information.
  • Rosuvastatin should not be used during pregnancy. Inform your healthcare professional if you are pregnant, planning pregnancy or become pregnant during treatment.
  • Discuss breastfeeding with your healthcare professional before using rosuvastatin.
  • Continue appropriate diet, physical activity and lipid monitoring as advised by your healthcare professional.
  • Do not take an additional rosuvastatin-containing medicine unless specifically prescribed.

For detailed prescribing and safety information, refer to the DailyMed information for Rosuvastatin.

Dosage & Administration

Take ROSUVST-20 exactly as prescribed by your healthcare professional.

The appropriate rosuvastatin dose depends on the patient’s LDL-C level, treatment goals, cardiovascular risk, age, kidney function, response to therapy and other clinical factors.

ROSUVST-20 can generally be taken once daily, with or without food, at any time of day. Swallow the tablet whole with water.

Do not increase the dose or take an additional tablet if you miss a dose. Follow your healthcare professional’s missed-dose instructions.

Storage

  • Store ROSUVST-20 in a cool, dry place.
  • Protect the tablets from excessive heat and moisture.
  • Keep the tablets in their original ALU-ALU packaging until use.
  • Protect from direct sunlight.
  • Keep out of the sight and reach of children.
  • Do not use the product after the expiry date printed on the pack.

Reviews

There are no reviews yet.

Be the first to review “ROSUVST-20”

Your email address will not be published. Required fields are marked *